Articles related to Adolescent Medicine

Six major US hospital systems have entered DOJ settlements involving pediatric gender-affirming care, resulting in service restrictions for patients under 19 and highlighting how federal enforcement activity can influence healthcare access beyond states with formal bans.

Nearly one in six pediatric GLP-1 receptor agonist users received a nutritional-deficiency or related diagnosis within one year, while nutrition counseling remained limited and generally occurred months after treatment initiation.

In a nationwide cohort of more than 2,700 U.S. children, parenting profiles characterized by higher positive engagement and stronger supervision were associated with fewer emotional and behavioral problems, while poorer supervision and inconsistent discipline were associated with greater symptom burden.

A report examining a celebrity-backed sports prediction campaign highlights concerns about increasing youth exposure to gambling-related marketing. The article connects growing gambling participation among adolescents and young adults with evidence linking gambling disorder to adverse mental health outcomes, including suicidality.

The FDA expanded the indication for olopatadine hydrochloride and mometasone furoate nasal spray to include children aged 6 to younger than 12 years with seasonal allergic rhinitis. Approval was supported by a phase 3 trial demonstrating improved nasal symptoms versus placebo.

A retrospective study of 606 pediatric patients found serum specific IgE testing for allergic rhinitis was frequently negative in children younger than 3 years and became more informative with age. Findings may aid diagnostic decision-making, though prospective validation is needed.